Tumor Promoting Effect of Long Non-Coding RNA RP11-556E13.1 and its Clinical Significance in Hepatocellular Carcinoma

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Hepatocellular carcinoma (HCC) is a major global health concern.
• Long non-coding RNAs (lncRNAs) play critical roles in various cancers, including HCC.
• The specific function and clinical significance of lncRNA RP11-556E13.1 (RP11) in HCC remain largely unexplored.

Purpose of the Study:

• To elucidate the functional role of lncRNA RP11 in hepatocellular carcinoma.
• To investigate the clinical significance and prognostic value of RP11 in HCC patients.

Main Methods:

• LncRNA and mRNA expression profiling using microarrays in HCC and adjacent tissues.
• Quantitative real-time PCR (sqRT-PCR) to validate RP11 expression.
• siRNA-mediated knockdown of RP11 in HCC cell lines.
• Cell proliferation, apoptosis, and cell cycle assays to determine RP11 function.
• Western blotting to assess protein expression changes.
• Bioinformatic analyses (GO and KEGG pathway enrichment) to explore underlying mechanisms.

Main Results:

• RP11 was significantly upregulated in HCC tissues compared to adjacent tissues (fold change = 20.24, p < 0.05).
• Higher RP11 expression correlated with larger tumor size, poorer differentiation, and lower overall survival in HCC patients (p < 0.05).
• RP11 knockdown inhibited HCC cell proliferation, induced apoptosis, and caused G1/S arrest, increasing cleaved PARP1 and cleaved caspase-3 levels.

Conclusions:

• lncRNA RP11 acts as an oncogene, promoting hepatocellular carcinoma progression.
• RP11 serves as a potential prognostic biomarker for HCC.